BMY - Latest News

Bristol-Myers Squibb Company (BMY), operates in Healthcare / Drug Manufacturers - General, trades on NYSE.

Market capitalization stands near $117.46B. Trailing twelve-month P/E ratio is 16.16. Beta to the broader market is 0.24.

The article list below shows the most recent BMY headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent BMY Headlines

Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term

zacks.com - Jun 30, 2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Merck, AbbVie probed by US lawmakers over China clinical trials: report

proactiveinvestors.com - Jun 30, 2026

A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including

Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

fool.com - Jun 30, 2026

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profil

Bristol Myers Squibb (BMY) Exceeds Market Returns: Some Facts to Consider

zacks.com - Jun 29, 2026

In the latest trading session, Bristol Myers Squibb (BMY) closed at $58. 56, marking a +1.

66 With $1.3 Million. Here Are 3 Hidden Gems to Target

247wallst.com - Jun 29, 2026

At 66 with $1. 3 million, the math is straightforward.

How News Affects BMY Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BMY's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked BMY news questions

What is the latest BMY news headline?

The most recent BMY headline (Jun 30, 2026) is "Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the BMY news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What BMY news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual BMY options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.